Brief: Crinetics Pharmaceuticals Q4 Net Income USD -122.815 Million
26/02/2026 21:05
Feb 26 (Reuters) - Crinetics Pharmaceuticals Q4 operating expenses USD 139.827 million. Q4 operating income USD -133.666 million Q4 basic EPS USD -1.29
Recent news on Crinetics Pharmaceuticals
See all newsNASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
Crinetics Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary
Crinetics Q2 revenue jumps on PALSONIFY launch, withdraws guidance
Brief: Crinetics Pharmaceuticals Q2 Net Income USD -120.855 Million